Weight Loss Pill Meridia Raises Heart Attack and Stroke Risks

Sept. 1, 2010 — People who take the weight loss pill Meridia have a higher risk of nonfatal heart attack and stroke. European regulatory authorities banned the drug known generically as Sibutramine and in Europe as Reductil. Later this month, an FDA expert advisory panel will meet to decide whether Meridia should remain on sale in the U.S. The FDA panel will make its recommendations on Sept. 15.

If you have taken Meridia and have had a heart attack or stroke, call us today at (210) 922-2200.

Depuy Hip Replacement

A subsidiary of Johnson and Johnson, DePuy Orthopaedics, issued a recall of its hip replacements after receiving a warning letter from the Food and Drug Administration (FDA) Health and Human Services. September 1, 2010, DePuy Orthopaedics began recalling its ASR Hip Systems, often used as hip replacements in hip replacement surgeries after approximately 1 out of every 8 patients experienced pain, complications, and required additional surgeries after being fitted with the ASR Hip System. Specific products being recalled include the: ASR XL Acetabular System and the DePuy ASR Hip Resurfacing System.

If you have either DePuy hip replacement and have been experiencing unusual swelling or persistent problems walking, contact Maloney & Campolo. You may be experiencing loosening of your hip replacement, fracturing of your bone, or dislocation due to your DePuy ASR hip replacement.

If you have a Depuy Hip Replacement, call us today at (210) 922-2200.